A review of the venous thrombotic issues associated with multiple myeloma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of the venous thrombotic issues associated with multiple myeloma
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 9, Issue 7, Pages 695-706
Publisher
Informa UK Limited
Online
2016-05-28
DOI
10.1080/17474086.2016.1194750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Venous Thromboembolic Disease
- (2017) Michael B. Streiff et al. Journal of the National Comprehensive Cancer Network
- Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma
- (2015) Heyu Huang et al. BLOOD COAGULATION & FIBRINOLYSIS
- Induction therapy alters plasma fibrin clot properties in multiple myeloma patients
- (2015) Anetta Undas et al. BLOOD COAGULATION & FIBRINOLYSIS
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- (2015) Z. Hanaizi et al. ONCOLOGIST
- Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients
- (2015) Sung-Eun Lee et al. THROMBOSIS RESEARCH
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
- (2015) Mourad Chaari et al. BMC CANCER
- Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
- (2014) P. G. Richardson et al. BLOOD
- miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis
- (2014) R. Norfo et al. BLOOD
- Venous Thromboembolism in Patients With Myeloma
- (2014) Maeve P. Crowley et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Pomalidomide: A Review of Its Use in Patients with Recurrent Multiple Myeloma
- (2014) Lesley J. Scott DRUGS
- Daratumumab granted breakthrough drug status
- (2014) Jacob P Laubach et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
- (2014) M. Engelhardt et al. HAEMATOLOGICA
- International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
- (2014) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
- (2014) M A Dimopoulos et al. LEUKEMIA
- Venous Thromboembolism in Multiple Myeloma
- (2014) Tommaso Za et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Inhibitory effects of bortezomib on platelet aggregation in patients with multiple myeloma
- (2014) Joanna Rupa-Matysek et al. THROMBOSIS RESEARCH
- Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
- (2014) M A Dimopoulos et al. Blood Cancer Journal
- Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens
- (2013) Tina Bagratuni et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myelome 2009-02
- (2013) X. Leleu et al. BLOOD
- Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients
- (2013) J. E. Geddings et al. BLOOD
- Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin
- (2013) Wan Z. Abdullah et al. BLOOD COAGULATION & FIBRINOLYSIS
- Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma
- (2013) Guillemette Fouquet et al. CANCER
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
- (2013) Jesus San Miguel et al. LANCET ONCOLOGY
- Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma
- (2013) Yu Isozumi et al. PLoS One
- MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs
- (2013) Philippe Rodon et al. THROMBOSIS AND HAEMOSTASIS
- Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib
- (2012) P. G. Richardson et al. BLOOD
- Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients
- (2012) Tommaso Za et al. BRITISH JOURNAL OF HAEMATOLOGY
- Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study
- (2012) Rachel Rosovsky et al. BRITISH JOURNAL OF HAEMATOLOGY
- Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients
- (2012) Patrizia Ferroni et al. Clinical Lung Cancer
- Thrombosis is associated with inferior survival in multiple myeloma
- (2012) S. Y. Kristinsson et al. HAEMATOLOGICA
- Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma
- (2012) G Cesarman-Maus et al. LEUKEMIA
- Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma
- (2012) Marta Robak et al. MEDICAL ONCOLOGY
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk and management of thrombosis in multiple myeloma
- (2012) Frank W.G. Leebeek et al. THROMBOSIS RESEARCH
- Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study
- (2012) Yesim Dargaud et al. THROMBOSIS RESEARCH
- Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
- (2011) M. Q. Lacy et al. BLOOD
- Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies
- (2011) Martha L Louzada et al. BLOOD COAGULATION & FIBRINOLYSIS
- Activated protein C resistance as measured by residual factor V after Russellʼs Viper Venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls
- (2011) Maurizio Zangari et al. BLOOD COAGULATION & FIBRINOLYSIS
- Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
- (2011) Elias J. Anaissie et al. CANCER
- Risk assessment models for cancer-associated venous thromboembolism
- (2011) Mrinal Dutia et al. CANCER
- Microparticles in Hemostasis and Thrombosis
- (2011) A. Phillip Owens et al. CIRCULATION RESEARCH
- Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens
- (2011) Maurizio Zangari et al. Clinical Lymphoma Myeloma & Leukemia
- Epidemiology, risk and outcomes of venous thromboembolism in cancer
- (2011) A. Falanga et al. Hamostaseologie
- Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
- (2011) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
- (2011) Cihan Ay et al. JOURNAL OF CLINICAL ONCOLOGY
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
- (2011) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement
- (2011) M A Dimopoulos et al. LEUKEMIA
- Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
- (2011) Elena Zamagni et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Prediction of venous thromboembolism in cancer patients
- (2010) C. Ay et al. BLOOD
- Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006
- (2010) D P Cronin-Fenton et al. BRITISH JOURNAL OF CANCER
- Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
- (2010) A. K. Gandhi et al. CURRENT CANCER DRUG TARGETS
- Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin
- (2010) Michela Cini et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism
- (2010) Henrik Gregersen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
- (2010) A. Palumbo et al. HAEMATOLOGICA
- Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
- (2010) Shinsuke Iida et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
- (2010) M Q Lacy et al. LEUKEMIA
- Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
- (2010) J. J. A. Auwerda et al. THROMBOSIS AND HAEMOSTASIS
- Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score
- (2010) Gregory C. Connolly et al. THROMBOSIS RESEARCH
- Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High-Dose Dexamethasone
- (2009) Maurizio Zangari et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
- (2009) David A. Manly et al. THROMBOSIS RESEARCH
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
- (2008) S. Y. Kristinsson et al. BLOOD
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started